Item(by='KraftKacke', descendants=None, kids=None, score=None, time=1610198523, title=None, item_type='comment', url=None, parent=25698672, text='AFAIK this is somewhat incorrect. Biotech switched to vaccine focus before SARS2 and the reason for the rapid development was the groundwork done for a SARS(1) vaccine.<p>It is also worth noting, the mRNA part wasn&#x27;t the innovative technology, but the nano lipid vehicle allowing immune evasion and cell fusion.<p>Because of that, the SARS2 pandemic fast tracked the tech for numerous targets and will benefit cancer medicine as well as future vaccine developments.')